Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special Reports
The 2025 Biotech Graveyard
Biotechs, beware: You're in for a scare.
Darren Incorvaia
Oct 31, 2025 5:00am
Novo makes bombshell $6.5B counteroffer to Pfizer's obesity buy
Oct 30, 2025 7:51am
Sponsored
First FDA IND Milestone Using Human Vascularized Organoid Data
Oct 27, 2025 8:00am
Thermo Fisher to buy Clario in $9B deal
Oct 31, 2025 12:41pm
Sponsored
iRegene's Scalable Tech Unlocks Commercial Cell Therapies
Oct 27, 2025 8:00am
Fierce Biotech Layoff Tracker 2025: Inventprise, Sensei & more
Oct 31, 2025 10:30am
More News
Biotech Graveyard
Oct 31, 2025 9:41am
Prominent vaccine critic ousted from HHS—Chutes & Ladders
Oct 31, 2025 8:30am
Nanobiotix finds new way to source cash from J&J-partnered drug
Oct 31, 2025 6:05am
Otsuka pens $420M deal for Asia rights to 4DMT gene therapy
Oct 31, 2025 5:09am
See more stories
